Lexapro for Major Depression in Patients With Epilepsy
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The primary objective will be to pilot the use of escitalopram for the treatment of major
depression in patients with epilepsy. The secondary objectives will be to determine effect
sizes on scales measuring depressive symptoms, physical symptoms, psychosocial function and
quality of life, and to evaluate safety in the population of patients with epilepsy.
These results will be used to evaluate the possibility of a future double-blind, placebo
controlled RCT of escitalopram for the treatment of major depression in patients with
epilepsy.